Opiant Pharmaceuticals skyrockets following deal to be acquired by Indivior Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Opiant Pharmaceuticals (OPNT) up 124% after announcing that it has entered into a definitive merger agreement to be acquired by a subsidiary of Indivior (INVVY) for $20.00 per share plus contingent value rights, or CVRs, representing, if achieved, potential additional payments over a period of seven years of up to $8.00 per share
- Biogen (BIIB) and Eli Lilly (LLY) up 4% and 2%, respectively, after Roche (RHHBY) announced the Phase III GRADUATE I and II studies evaluating gantenerumab in people with mild cognitive impairment due to Alzheimer's and mild Alzheimer's dementia did not meet their primary endpoints
UP AFTER EARNINGS -
- PDS Biotechnology (PDSB) up 22%
- Monday.com (MNDY) up 23%
- Magic Software (MGIC) up 10%
- Tower Semiconductor (TSEM) up 4%
- Tyson Foods (TSN) up 1%
- Roivant Sciences (ROIV) up 3%
- Palatin (PTN) up 3%
DOWN AFTER EARNINGS -
- Oatly Group (OTLY) down 12%
- Gracell (GRCL) down 10%
- Point Biopharma (PNT) down 2%
Symbols:
OPNT LLY - $351.44 /
-15.56 (-4.24%)
BIIB TSN TSEM MNDY - $95.27 /
+11.44 (+13.65%)
PDSB MGIC PNT OTLY GRCL ROIV PTN INVVY RHHBY Keywords: Fly Intel, Wall Street, Top Stories, Stocks